BioHealth News Archive
ATCC Licenses CRISPR/Cas9 Technology from the Broad Institute – Meets untapped needs with release of new isogenic cell line
ATCC, the premier global biological materials resource and standards organization, announces today that it licensed CRISPR/Cas9 gene editing technology from the Broad Institute of…
Read More
Emergent Bio licenses Ligand Pharma’s technology to augment its discovery of new antibodies – Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) | Seeking Alpha
Ligand Pharmaceuticals enters into a global license agreement with Emergent BioSolutions under which Emergent will use Ligand's OmniRat, OmniMouse and OmniFlic technologies to discover…
Read More
Newly published Licensing Activity Survey report drills down to data detail | AUTM
AUTM today released its highly regarded annual U.S. Licensing Activity Survey report for FY2014. Along with real world and human impact stories about technology transfer’s…
Read More
MedImmune and UCFS Announce Seven-Project Partnership – GEN News
In a partnership announced today, MedImmune, AstraZeneca’s global biologics and development arm, and the University of California, San Francisco will initiate further exploration of…
Read More
Qiagen Inks Master CDx Collaboration With Array BioPharma | GenomeWeb
NEW YORK (GenomeWeb) – Qiagen said yesterday that it has inked a master collaboration for companion diagnostics codevelopment with Array BioPharma, the 15th pharma…
Read More
HHS Idea Lab launches initiative to help consumers participate in medical device development – MedCity NewsMedCity News
The way Health and Human Services Chief Technology Officer Susannah Fox sees it, the U.S. government totally missed the Internet boom and has been…
Read More
Advanced Accelerator Applications (AAAP) Enters Exclusive Deal With Johns Hopkins University for Prostate Cancer
Advanced Accelerator Applications S.A. (NASDAQ: AAAP) announced an exclusive license agreement with Johns Hopkins University in Baltimore, Maryland to develop and market PSMA-SR6, a…
Read More
AstraZeneca and Moderna Therapeutics Announce New Collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics™ | Business Wire
AstraZeneca, along with its global biologics research and development arm, MedImmune, and Moderna Therapeutics today announced a new collaboration to discover, co-develop and co-commercialize…
Read More
Dreamit Partners With Independence Blue Cross And Penn Medicine To Launch Revamped Dreamit..
Leading global start up accelerator Dreamit today announced that it has renewed its partnerships with industry leaders Independence Blue Cross (Independence) and Penn Medicine…
Read More
Why NIH Wants to Change Incentives for Researchers – Nextgov.com
Biological researchers should be able to share datasets the same way they share published scientific articles — at least, that’s what the National Institutes…
Read More
‘Renaissance’ ideas – Piero Formica – LinkedIn
Rewards for creative people; investments in new ideas that challenge the power of the Pope and sovereign rulers, that give impetus to science and…
Read More
AMA invests $15 million to launch Silicon Valley innovation hub Health2047 | Healthcare IT News
The American Medical Association has invested $15 million to become founding partner of Health2047, a high-tech incubator that will explore innovative solutions to some of the…
Read More
Rockville-based Sucampo Pharmaceuticals Inc. acquires exclusive option for colon cancer prevention drug in deal worth up to $190 million – Washington Business Journal
Sucampo Pharmaceuticals (NASDAQ:SCMP) has acquired an option to commercialize a drug candidate aimed at preventing colon cancer among a high-risk group of patients in…
Read More
NEXT WEEK! Join BioBuzz & JHU in Gaithersburg on 1/21
Thursday January 21, 2016 from 5:00 PM to 7:00 PM EST Johns Hopkins Montgomery County Campus is also a site for the popular Osher…
Read More
Sucampo Pharma (SCMP) Enters Option Agreement to License CPP-1X/Sulindac Product in North America
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP) announced an option and collaboration agreement under which Cancer Prevention Pharmaceuticals, Inc. (CPP) has granted Sucampo the sole…
Read More